Michael Hughes, MD
Transplant Surgery · Louisville, KYNPI 1831133644
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,892 of the $4,722 with a category attached, or 61.2%. 12 manufacturers reported payments, led by Medtronic at 48.3% of the total.
Across 60 payments — averaging $78.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Enterra Medical, Inc.$1K
- Amgen$404
- Evoke Pharma, Inc.$308
- Merz North America, Inc.$250
- Merit Medical Systems Inc$124
- plus $206 from 6 others
What the payments were for
- Consulting fees$63013%
- Speaking & faculty fees$1,20025%
- Food & beverage$2,89261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 21 | $2,282 |
| Enterra Medical, Inc. | 7 | $1,148 |
| Amgen | 14 | $404 |
| Evoke Pharma, Inc. | 8 | $308 |
| Merz North America, Inc. | 1 | $250 |
| Merit Medical Systems Inc | 1 | $124 |
| Alcresta Therapeutics, Inc. | 1 | $57 |
| Vertex | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Stryker | 1 | $26 |
| Lexington Medical, Inc. | 1 | $21 |
| AbbVie | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few transplant surgery providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 21 | $1,252 |
| Oxycodone Hcl | 51 | $133 |
| Pantoprazole Sodium | 12 | $61 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Louisville
- Eric DavisLouisville$78K
- Christopher JonesLouisville$34K
- Mary EngLouisville$6K
- Yaser Al-SalmayLouisville$850
- Alejandro Cracco MahechaLexington$5K
- Malay ShahLexington$5K
- Meera GuptaLexington$3K
- Siddharth DesaiLexington$3K
- Alexandre AnchetaLexington$3K
- Matthew BlackLexington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.